Hinze, Claas H. http://orcid.org/0000-0001-9247-4729
Oommen, Prasad T.
Dressler, Frank
Urban, Andreas
Weller-Heinemann, Frank
Speth, Fabian
Lainka, Elke
Brunner, Jürgen
Fesq, Heike
Foell, Dirk
Müller-Felber, Wolfgang
Neudorf, Ulrich
Rietschel, Christoph
Schwarz, Tobias
Schara, Ulrike
Haas, Johannes-Peter
Funding for this research was provided by:
Initiative für das rheumakranke Kind
u can ride 4 arthritis
Article History
Received: 1 March 2018
Accepted: 13 June 2018
First Online: 25 June 2018
Ethics approval and consent to participate
: The national pediatric rheumatology database was approved by the ethics committee of the Charité in Berlin.
: Not applicable.
: Dr. Hinze has received consulting fees, speaking fees, and/or honoraria from Novartis (less than $10,000 each). Dr. Oommen reports no potential competing interests. Dr. Dressler has received consulting fees, speaking fees, and/or honoraria from Novartis and Pfizer (less than $10,000 each). Dr. Weller-Heinemann has received honoraria from Abbvie, Novartis and Pfizer (less than $10,000 each). Dr. Lainka has received consulting fees, speaking fees, and/or honoraria from Novartis (less than $10,000 each) and research support from Sobi. Dr. Brunner has received consulting fees, speaking fees, and/or honoraria from Abbvie, MSD, Novartis, Pfizer and Roche (less than $10,000 each). Dr. Föll is a board member of the Society for Pediatric Rheumatoloy and has received honoraria from Novartis, Pfizer, Roche-Chugai and Sobi (less than $10,000 each) and research support from Novartis and Pfizer. Dr. Neudorf has received consulting fees, speaking fees, and/or honoraria from Chugai and Philips (less than $10,000 each), and research support from Novartis. Dr. Schwarz reports no potential competing interests. Dr. Schara is president of the Gesellschaft für Neuropädiatrie (GNP; Society for Pediatric Neurology in Germany) and has received consulting fees, speaking fees, and/or honoraria from PTC Therapeutics, Deutsche Myasthenie Gesellschaft (German Myasthenia Society) and benni &co (a non-profit organization benifitting patients with muscular dystrophy). Dr. Haas is the president of the Society for Pediatric Rheumatology has received research support from Novartis and Pfizer.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.